CYP2C19 genotype and cardiovascular events

JAMA. 2012 Apr 11;307(14):1482-3; author reply 1484-5. doi: 10.1001/jama.2012.444.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Cardiovascular Diseases / epidemiology*
  • Hemorrhage / epidemiology*
  • Humans
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / metabolism*
  • Ticlopidine / analogs & derivatives*

Substances

  • Platelet Aggregation Inhibitors
  • Aryl Hydrocarbon Hydroxylases
  • Ticlopidine